SEC Form 4 · accession 0001209191-18-033897
Iterum Therapeutics plc · ITRM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Brenton Karl Ahrens
Director
Period of report
May 24, 2018
Accepted (ET)
May 29, 2018 · 5:17 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001659323
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F2 | — | May 24, 2018 | A | 6,154 | A | — | — | Ordinary Shares | 6,154 | 6,154 | D |
Explanation of responses
- F1Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Ordinary Shares.
- F2Subject to the Reporting Person providing continuous service, the RSU shall vest on May 24, 2019.